Page last updated: 2024-08-24

nelfinavir and Cytomegalovirus

nelfinavir has been researched along with Cytomegalovirus in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boucoiran, I; Burchett, S; Frenkel, L; Gantt, S; Huang, ML; Jacobsen, DL; Jerome, KR; Jourdain, G; Leister, E; Ngo-Giang-Huong, N	1
Carlsson, J; Casper, C; Corey, L; Gachelet, E; Gantt, S; Geballe, AP; Gray, M; Ikoma, M; Lagunoff, M; Vieira, J	1
Badley, A; Castedo, M; Kroemer, G; Métivier, D; Paulau, AL; Perfettini, JL; Rizzuto, R; Roumier, T; Simoni, AM; Szabadkai, G	1
Bart, PA; Chapuis, AG; Lazzarin, A; Pantaleo, G; Rizzardi, GP; Tambussi, G	1

Trials

1 trial(s) available for nelfinavir and Cytomegalovirus

Article	Year
Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count. AIDS (London, England), 2000, Oct-20, Volume: 14, Issue:15 Topics: Adult; Anti-HIV Agents; Antigens, Fungal; Antigens, Viral; Antiretroviral Therapy, Highly Active; Candida albicans; Carbamates; CD4 Lymphocyte Count; Chronic Disease; Cytomegalovirus; Dideoxynucleosides; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Nelfinavir; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Simplexvirus; Sulfonamides; T-Lymphocyte Subsets	2000

Article

Year

Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.

AIDS (London, England), 2000, Oct-20, Volume: 14, Issue:15

Topics: Adult; Anti-HIV Agents; Antigens, Fungal; Antigens, Viral; Antiretroviral Therapy, Highly Active; Candida albicans; Carbamates; CD4 Lymphocyte Count; Chronic Disease; Cytomegalovirus; Dideoxynucleosides; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Nelfinavir; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Simplexvirus; Sulfonamides; T-Lymphocyte Subsets

2000

Other Studies

3 other study(ies) available for nelfinavir and Cytomegalovirus

Article	Year
Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy. Journal of medical virology, 2016, Volume: 88, Issue:6 Topics: Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Risk Factors; Young Adult	2016
The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6 Topics: Adenoviridae; Alkaline Phosphatase; Animals; Chlorocebus aethiops; Cytomegalovirus; Herpesvirus 1, Human; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Nelfinavir; Vaccinia virus; Vero Cells; Virus Replication	2011
HIV-1 protease inhibitors and cytomegalovirus vMIA induce mitochondrial fragmentation without triggering apoptosis. Cell death and differentiation, 2006, Volume: 13, Issue:2 Topics: Apoptosis; Calcium; Ceramides; Cytomegalovirus; Giant Cells; HeLa Cells; HIV Protease Inhibitors; Humans; Hydrogen Peroxide; Immediate-Early Proteins; Inhibitor of Apoptosis Proteins; Macrophage Inflammatory Proteins; Mitochondria; Nelfinavir; Ritonavir; Saquinavir; Tumor Suppressor Protein p53; Viral Proteins	2006